Posco shares climb in Seoul on joint-venture semiconductor project
By Kwanwoo Jun
Posco Holdings' shares climbed after the steelmaker unveiled a joint venture project to produce rare gases for making semiconductors in South Korea.
Posco (KR:005490) rose as much as 7.3% to 508,000 won ($391.85) in early trade Wednesday, outperforming the benchmark Kospi's KR:180721 0.1% fall.
The stock's rally, which snapped a three-session losing streak, came after Posco and China's Zhongtai Cryogenic Technology (CN:300435)agreed to jointly build a plant to produce high-purity neon, krypton and xenon gases.
The JV would produce 130,000 normal cubic meters of rare gases annually, about 52% of South Korean chip makers' total needs, according to Posco.
Posco and Zhongtai plan to break ground in 2024 to build the JV plant in the South Korean southern port of Gwangyang and start production in late 2025.
Posco said its Chinese partner would hold a 24.9% stake in the JV, while it would hold the remaining 75.1% stake. Posco didn't disclose financial terms.
The JV would "contribute to stabilizing the supply chain by domestically producing high-purity rare gases for semiconductors, which have been mostly imported," Posco said in a statement.
The global supply chain has been disrupted by the ongoing war between Ukraine and Russia, which are main suppliers of high-purity rare gases.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-26-23 2303ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise